Shailja Vaghela

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 15

Top Topics

Systematic Review

Respiratory Syndrome Coronavirus

Top Venues

Orphanet journal of rare diseases

Expert review of vaccines

Healthcare (Basel, Switzerland)

Dermatology and therapy

This page only lists publications with an associated author ORCID identifier.

Publications

Shailja Vaghela, Kaniz Afroz Tanni, Geetanjoli Banerjee, Vanja Sikirica
A systematic review of real-world evidence (RWE) supportive of new drug and biologic license application approvals in rare diseases. Orphanet journal of rare diseases 19 (1) (2024)
Shailja Vaghela, Kaniz Afroz Tanni, Geetanjoli Banerjee, Vanja Sikirica
A systematic review of real-world evidence (RWE) supportive of new drug and biologic license application approvals in rare diseases. Orphanet journal of rare diseases 19 (1) (2024)
Shailja Vaghela, Verna L Welch, Anup Sinh, Manuela di Fusco
Caregiver Burden among Patients with Influenza or Influenza-like Illness (ILI): A Systematic Literature Review. Healthcare (Basel, Switzerland) 12 (16) (2024)
Shailja Vaghela, Verna L Welch, Anup Sinh, Manuela di Fusco
Caregiver Burden among Patients with Influenza or Influenza-like Illness (ILI): A Systematic Literature Review. Healthcare (Basel, Switzerland) 12 (16) (2024)
Shailja Vaghela, Kaniz Afroz Tanni, Geetanjoli Banerjee, Vanja Sikirica
A systematic review of real-world evidence (RWE) supportive of new drug and biologic license application approvals in rare diseases. Orphanet journal of rare diseases 19 (1) (2024)
Shailja Vaghela, Kaniz Afroz Tanni, Geetanjoli Banerjee, Vanja Sikirica
A systematic review of real-world evidence (RWE) supportive of new drug and biologic license application approvals in rare diseases. Orphanet journal of rare diseases 19 (1) (2024)
Shailja Vaghela, Kaniz Afroz Tanni, Geetanjoli Banerjee, Vanja Sikirica
A systematic review of real-world evidence (RWE) supportive of new drug and biologic license application approvals in rare diseases. Orphanet journal of rare diseases 19 (1) (2024)
Shailja Vaghela, Kaniz Afroz Tanni, Geetanjoli Banerjee, Vanja Sikirica
A systematic review of real-world evidence (RWE) supportive of new drug and biologic license application approvals in rare diseases. Orphanet journal of rare diseases 19 (1) (2024)
Shailja Vaghela, Kaniz Afroz Tanni, Geetanjoli Banerjee, Vanja Sikirica
A systematic review of real-world evidence (RWE) supportive of new drug and biologic license application approvals in rare diseases. Orphanet journal of rare diseases 19 (1) (2024)
Jingyan Yang, Guilherme Cordeiro, Mauricio Longato, Shailja Vaghela, Moe H Kyaw, Carlos Fernando Mendoza, Ana Dantas, Thais Senna, Pedro Holanda, Julia Regazzini Spinardi
Burden of COVID-19 during the omicron predominance in Brazil: a nationwide retrospective database study. Journal of medical economics (2023)
Jingyan Yang, Shailja Vaghela, Benjamin Yarnoff, Solene De Boisvilliers, Manuela di Fusco, Timothy Lee Wiemken, Moe Htet Kyaw, John M McLaughlin, Jennifer L Nguyen
Estimated global public health and economic impact of COVID-19 vaccines in the pre-omicron era using real-world empirical data. Expert review of vaccines 22 (1) (2022)
Jingyan Yang, Shailja Vaghela, Benjamin Yarnoff, Solene De Boisvilliers, Manuela di Fusco, Timothy Lee Wiemken, Moe Htet Kyaw, John M McLaughlin, Jennifer L Nguyen
Estimated global public health and economic impact of COVID-19 vaccines in the pre-omicron era using real-world empirical data. Expert review of vaccines 22 (1) (2022)
Kavita Gandhi, Morgan E Shy, Markqayne Ray, Moshe Fridman, Shailja Vaghela, Arash Mostaghimi
The Association of Alopecia Areata-Related Emotional Symptoms with Work Productivity and Daily Activity Among Patients with Alopecia Areata. Dermatology and therapy (2022)
Jingyan Yang, Shailja Vaghela, Benjamin Yarnoff, Solene De Boisvilliers, Manuela di Fusco, Timothy Lee Wiemken, Moe Htet Kyaw, John M McLaughlin, Jennifer L Nguyen
Estimated global public health and economic impact of COVID-19 vaccines in the pre-omicron era using real-world empirical data. Expert review of vaccines 22 (1) (2022)
Jingyan Yang, Shailja Vaghela, Benjamin Yarnoff, Solene De Boisvilliers, Manuela di Fusco, Timothy Lee Wiemken, Moe H Kyaw, John M McLaughlin, Jennifer L Nguyen
Estimated global public health and economic impact of COVID-19 vaccines in the pre-omicron era using real-world empirical data. Expert review of vaccines (2022)